| 3CL-Pro | 3-Chymotripsin-like protease |
| 6PGDH | 6-Phosphogluconate dehydrogenase |
| 253J | Human bladder cancer cell line |
| ABCG2 | ATP-binding cassette transporter G2 |
| ACC-2 | Salivary adenoid cystic carcinoma cell line |
| ACC-M | Salivary adenoid cystic carcinoma cell line |
| ACE2 | Angiotensin-converting enzyme 2 |
| AIDS | Acquired immunodeficiency syndrome |
| AKT | Protein kinase B |
| ALDH1 | Aldehyde dehydrogenase 1 |
| AMP | Adenosine monophosphate |
| AMPK | AMP-activated protein kinase |
| AOM | Azoxymethane |
| AP-1 | Activator protein 1 |
| ARE | Antioxidant response elements |
| βAS | β-Amyrin synthase |
| B16F10 | B16 melanoma cell line |
| BA | Betulinic acid |
| Bad | Pro-apoptotic BH3-only protein Bad |
| Bax | Pro-apoptotic Bcl-2-associated X protein |
| Bcl-2 | Anti-apoptotic B-cell lymphoma 2 |
| BGC-803 | Gastric cancer cell line |
| Bid | Pro-apoptotic BH3 Interacting domain death agonist |
| Bim | Pro-apoptotic Bcl-2 homology 3-only protein Bim |
| BT474 | Human breast carcinoma cell line |
| CA | Caffeic acid |
| Caco-2 | Caucasian colon adenocarcinoma cell line |
| Caspase | Cysteine-dependent aspartate-directed protease |
| CAT | Catalase |
| CCL2/MPC-1 | Chemokine (C-C motif) ligand2/monocyte chemoattractant protein 1 |
| CCl4 | Carbon tetrachloride |
| CD44 | Cell-surface glycoprotein involved in cell–cell interactions, adhesion and migration |
| CNS | Catecholaminergic cell line |
| COMT | Catechol-O-methyltransferase |
| COVID-19 | Coronavirus disease 2019 |
| COX2 | Cyclooxygenase 2 |
| Cripto-1 | Epidermal growth factor CFC-1 |
| CRC | Colorectal cancer |
| CRP | C-reactive protein |
| CS | Protein-synthesis capacity |
| CSC | Cancer stem cell |
| CT | Clinical trial |
| CXCL10/IP-10 | C-X-C motif chemokine ligand 10/interferon gamma-induced protein 10 |
| DHPA | Dihydroxyphenylacetic acid |
| DMT2 | Diabetes mellitus type 2 |
| DNA | Deoxyribonucleic acid |
| DSS | Dextran sulphate sodium |
| eNOS | Endothelial nitric oxide synthase |
| EO | Erythrodiol |
| EMT | Epithelial–mesenchymal transition |
| EVOO | Extra virgin olive oil |
| ErbB2 | Receptor tyrosine-protein kinase erbB-2 |
| G6PDH | Glucose 6 phosphate dehydrogenase |
| GPX | Glutathione peroxidase |
| GR | Glutathione reductase |
| GSH | Glutathione reduced |
| GSSG | Glutathione oxidized |
| GST | Glutathione S-transferase |
| H22 | Hepatocellular cancer cell line |
| H2O2 | Hydrogen peroxide |
| HCT116 | Human colon cancer cell line |
| HepG2 | Human liver cancer cell line |
| HIV-1 | Human immunodeficiency virus-1 |
| HL60 | Human promyelocytic leukemia cell line |
| HO-1 | Heme oxygenase 1 |
| HPLC | High performance liquid chromatography |
| HSP60 | Heat shock proteins (chaperon) |
| HSP70 | Heat shock proteins (chaperon) |
| HSPA | Low molecular weight heat shock protein (chaperon) |
| HT | Hydroxytyrosol |
| HT29 | Human colorectal adenocarcinoma cell line |
| HVA | Homovanillic acid |
| HVOL | Homovanillic alcohol |
| IC50 | Concentration of a drug that gives half-maximal response |
| IL | Interleukins |
| iNOS | Inducible nitric oxide synthase |
| J774 | Macrophage cell line |
| JNK | Jun N-terminal kinase |
| KD | Protein degradation rate |
| KDNA | Protein synthesis rate/DNA unit |
| KG | Protein accumulation rate |
| KRNA | Protein synthesis efficiency |
| KS | Protein synthesis rate |
| LD50 | Median lethal dose |
| LDL | Low-density lipoprotein |
| LP | Lipoperoxide |
| LPO | Lipid peroxidation |
| LPS | Lipopolysaccharide |
| MA | Maslinic acid |
| MAPK | Mitogen-activated protein kinase |
| MCF-7 | Michigan cancer foundation-7/breast cancer cell line |
| MDA-MB-231 | Triple-negative breast cancer cell line |
| MDCK | Madin-Darby Canine Kidney cells |
| MIP1β | Macrophage inflammatory protein 1 βeta |
| miRNA, miR | Micro RNA |
| MMP | Mitochondrial membrane potential |
| MMP9 | Matrix metallopeptidase 9 |
| mRNA | Messenger ribonucleic acid |
| MS | Mass spectrometry |
| MT2 | Human T cell leukemia |
| mTOR | Mechanistic target of rapamycin kinase |
| MUFA | Monounsaturated fatty acids |
| NADP | Nicotinamide adenine-dinucleotide phosphate oxidized |
| NADPH | Nicotinamide adenine-dinucleotide phosphate reduced |
| NADP-ICDH | Isocitrate dehydrogenase NADP dependent |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated beta cells |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| NTPs | Nucleoside triphosphates |
| O2•− | Superoxide anion radical |
| OA | Oleanolic acid |
| ODC | Ornithine decarboxylase |
| OE | Oleuropein |
| OS | (3S)-2,3-Epoxi-2,3-dihidroescualeno |
| OSC | (3S)-2,3-Epoxi-2,3-dihidroescualeno-lanosterol cyclase, also named lanosterol synthase |
| p21WAF/CIP1 | Cyclin-dependent kinase inhibitor A1 |
| p24 | HIV p24 protein (CA, core antigen) |
| p27Kip1 | Cyclin-dependent kinase inhibitor |
| p53 | Tumor suppressor protein 53 |
| p90Rsk | Ribosomal S MAPK-activated protein kinase-1 |
| PDCD4 | Programmed cell death protein 4 |
| PGES | Prostaglandin E synthase |
| PI3K | Phosphoinositide 3-kinase |
| PL-Pro | Papain-like protease |
| PMA | Phorbol 12-myristate 13-acetate |
| PPP | Pentose phosphate pathway |
| PRE | Protein retention efficiency |
| PUFA | Polyunsaturated fatty acids |
| RdRp | RNA-dependent RNA polymerase |
| ROS | Reactive oxygen species |
| RPS6KA2 | Ribosomal Protein S6 Kinase A2 gene |
| RT4 | Urinary bladder transitional cell carcinoma |
| SARS-CoV-2 | Severe acute respiratory syndrome Coronavirus 2 |
| SGp-RBD | Spike glycoprotein receptor binding domain |
| SH-SY5Y | Human neuroblastoma cell line |
| SK-UT-1 | Human leiomyosarcoma cell line |
| SOD | Superoxide dismutase |
| Sp | Specific protein transcription factors |
| SSDE | Steady state of dynamic equilibrium |
| STAT3 | Signal transducer and activator of transcription 3 |
| SW480 | Human colon cancer cell line |
| SW982 | Human synovial sarcoma cell line |
| T24 | Human urothelial bladder cancer cell line |
| TGF-β1 | Transforming growth factor β1 |
| Th9 | T helper type 9 cell line |
| THP-1 | Human leukemia monocytic cell line |
| TNFα | Tumor necrosis factor α |
| TXA2 | Thromboxane A2 |
| TXB2 | Thromboxane B2 |
| U-251 MG | Malignant glioblastoma cell line |
| UA | Ursolic acid |
| UO | Uvaol |
| VEGFR | Vascular endothelial growth factor receptor |
| WRL68 | Normal human liver cell line |
| YY1 | Yin Yang1 transcriptional repressor |
| ZBRB10 | Zinc finger and BTB domain-containing protein 10 |